tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Steven Seedhouse - 15 which are a Hold (7.73%), 179 which are a Buy (92.27%)
Analyst Steven Seedhouse works at RAYMOND JAMES and is covering Healthcare, Industrials sectors with 360 price targets and ratings displayed on 30 stocks.
Steven Seedhouse's average stock forecast success ratio is 43.39% with an average time for price targets to be met of 244.29 days.
Most recent stock forecast was given on NTLA, Intellia Therapeutics at 10-Nov-2023.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/29/2021. The price target of $168 was fulfilled within 2 days with a profit of $16.39 (10.81%) receiving and performance score of 54.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
173
$-9.5 (-5.21%)
156
2 years 7 months 2 days ago
14/24 (58.33%)
$55.25 (44.76%)
682
Hold
166
$-16.5 (-9.04%)
175
2 years 10 months 1 days ago
26/26 (100%)
$55.25 (49.07%)
828
Buy
155
2 years 10 months 28 days ago
7/7 (100%)
$42.28 (38.07%)
395
Buy
175
$-7.5 (-4.11%)
155
2 years 11 months 19 days ago
13/17 (76.47%)
$42.47 (34.95%)
944
Hold
157
2 years 11 months 20 days ago
2/2 (100%)
$40.4 (37.02%)
256
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
